Great Bay Bio, a Hong Kong-based high-tech enterprise dedicated to applying artificial intelligence and other technologies in CMC bioprocessing, completed a near USD10M Series A funding. The round was led by Proxima Ventures with participation from many new and existing institutional investors.
Read more: https://bit.ly/3lxkAbJ